Home  »  Markets   »  Inovio Pharmaceuticals Inc. (INO) recently have ta...

Inovio Pharmaceuticals Inc. (INO) recently have taken one step ahead with the beta value of 0.57

Inovio Pharmaceuticals Inc. (NASDAQ: INO) open the trading on November 24, 2021, with great promise as it jumped 0.29% to $6.92. During the day, the stock rose to $6.965 and sunk to $6.675 before settling in for the price of $6.90 at the close. Taking a more long-term approach, INO posted a 52-week range of $5.81-$19.00.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


>> 7 Top Picks for the Post-Pandemic Economy << 

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -28.80%. Meanwhile, its Annual Earning per share during the time was -20.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 11.30%. This publicly-traded company’s shares outstanding now amounts to $210.31 million, simultaneously with a float of $206.92 million. The organization now has a market capitalization sitting at $1.43 billion. At the time of writing, stock’s 50-day Moving Average stood at $7.15, while the 200-day Moving Average is $8.40.

Let’s gauge the efficiency of the firm, which has a total of 262 employees. It has generated 28,287 per worker during the last fiscal year. Meanwhile, its income per employee was -635,157. The stock had 0.70 Receivables turnover and 0.02 Total Asset turnover. For the Profitability, stocks operating margin was -1760.60 and Pretax Margin of -2197.89.

Inovio Pharmaceuticals Inc. (INO) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Inovio Pharmaceuticals Inc.’s current insider ownership accounts for 0.10%, in contrast to 37.70% institutional ownership. According to the most recent insider trade that took place on Aug 09, this organization’s Chief Scientific Officer sold 10,317 shares at the rate of 9.15, making the entire transaction reach 94,401 in total value, affecting insider ownership by 68,587. Preceding that transaction, on Jun 09, Company’s Chief Operating Officer sold 38,535 for 10.01, making the whole transaction’s value amount to 385,735. This particular insider is now the holder of 21,592 in total.

Inovio Pharmaceuticals Inc. (INO) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 9/29/2021 suggests? It has posted -$0.29 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.33) by $0.04. This company achieved a net margin of -2245.39 while generating a return on equity of -71.64. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.

Inovio Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 11.30% and is forecasted to reach -0.82 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 45.80% through the next 5 years, which can be compared against the -20.20% growth it accomplished over the previous five years trading on the market.

Inovio Pharmaceuticals Inc. (NASDAQ: INO) Trading Performance Indicators

Let’s observe the current performance indicators for Inovio Pharmaceuticals Inc. (INO). It’s Quick Ratio in the last reported quarter now stands at 9.50. The Stock has managed to achieve an average true range (ATR) of 0.35. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 219.42.

In the same vein, INO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.09, a figure that is expected to reach -0.28 in the next quarter, and analysts are predicting that it will be -0.82 at the market close of one year from today.

Technical Analysis of Inovio Pharmaceuticals Inc. (INO)

[Inovio Pharmaceuticals Inc., INO] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 27.27% While, its Average True Range was 0.36.

>> 7 Top Picks for the Post-Pandemic Economy << 

Raw Stochastic average of Inovio Pharmaceuticals Inc. (INO) in the period of the previous 100 days is set at 16.02%, which indicates a major fall in contrast to 33.49% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 40.82% that was lower than 56.36% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam